-The Indian Express Responding to specific queries on the issue, Bhupendra Singh, NPPA chairman, told The Indian Express that “examination of hospital records is in process”. AFTER the National Pharmaceutical Pricing Authority (NPPA) in February ordered a cap on the prices of coronary stents and directed hospitals to issue separate bills specifying their cost, the drug pricing watchdog has started receiving consumer complaints against hospitals which are allegedly hiking the prices...

-The Times of India Multinational stent companies claim that the ceiling price fixed by the National Pharmaceutical Pricing Authority (NPPA) is commercially unviable, but they are selling at far lower prices in much richer countries with smaller markets than India such as Germany, the UK, Italy and many other European countries. A look at the prices of stent brands in these countries shows that people in India have been defrauded of crores...

-The Hindu Doctors’ objections to prescribing medicines by generic names fly in the face of a recent report on substandard drugs In a surprise move on April 17, Prime Minister Narendra Modi announced that his government will soon make it mandatory for doctors to prescribe medicines by generic names. The decision was to ensure drug prices remain affordable and Patients get a wider bouquet of options instead of being forced to...

-Business Standard/ India Spend Under-nutrition increases the severity of TB, reduces Patients' speed of recovery Mt Abu/Abu Road: One look at Puni Garasia, 14, was all it took Ashok Dave, a doctor operating a charitable mobile clinic service for 56 dusty, desolate hamlets in Sirohi, southwest Rajasthan, to suspect tuberculosis (TB). “She was all skin and bones,” Dave, an employee of Global Hospital & Research Centre, a health not-for-profit, told IndiaSpend. On March 24,...

-The Hindu By 2040, 12.4% of Patients in the country will have that variant, reports Lancet A month after the Health Ministry set itself the target of eliminating tuberculosis (TB) by 2025, a new study in the medical journal Lancet says that India’s TB crisis is likely to get worse. According to the latest issue of the journal, Multidrug Resistant-Tuberculosis (MDR-TB), a version of the disease where Patients do not respond to first-line...